What Is the VA Rating for Asthma? DC 6602 Criteria, Burn Pit Presumptive, and the PFT Testing Strategy

The VA rates asthma under Diagnostic Code 6602 at exactly four levels: 10%, 30%, 60%, or 100%. There are no intermediate tiers. No 20%, no 40%, no 50%. You land on one of those four numbers or you get nothing.

That structure alone creates problems. But the real damage happens in how the VA tests and decides which tier you fall into. The rating hinges on Pulmonary Function Test (PFT) results, specifically your FEV-1 and FEV-1/FVC ratios. And buried in the regulations is a fact that almost no veteran-facing resource explains: DC 6602 is not listed in the post-bronchodilator requirement at 38 CFR 4.96(d)(4). That means the VA must use whichever PFT result — pre or post-bronchodilator — gives you the higher rating. Most C&P examiners do not know this. Most veterans do not know this. And it is costing veterans entire rating tiers.

Then there is the medication distinction. The difference between 30% and 60% often comes down to whether your corticosteroid is inhalational (Flovent, Symbicort, Advair) or systemic (oral prednisone, methylprednisolone, dexamethasone). Inhalational maxes out at 30%. Systemic at three or more courses per year gets you to 60%. That single word — systemic versus inhalational — is a $10,000-per-year swing in tax-free compensation.

This guide covers every rating tier, the PACT Act burn pit presumptive, the PFT testing strategy your examiner will not volunteer, secondary conditions, constrictive bronchiolitis, and the TDIU pathway that turns a 60% asthma rating into 100% compensation.

DC 6602 Rating Criteria: The Complete Table

The VA rates bronchial asthma under 38 CFR 4.97, Diagnostic Code 6602. Each rating level can be reached through PFT results or medication and clinical criteria — you only need to meet one pathway within a tier, not all of them.

Here are the exact rating thresholds from the regulatory text:

What the 0% Scenario Looks Like

If you have a verified history of asthmatic attacks but no current clinical findings and your PFTs are above 80% predicted, the VA may grant service connection at 0%. This is not a denial — it is a foothold. A 0% rating establishes the nexus. You can file for an increased rating at any time with updated PFT evidence or medication records showing your condition has worsened. VA OIG data shows a significant percentage of asthma approvals come in at 0%, which veterans should treat as a foundation for secondary claims and future increases — not as a final answer.

FEV-1 and FEV-1/FVC: What the PFT Numbers Mean

FEV-1 (Forced Expiratory Volume in 1 second) is the amount of air you can forcefully exhale in the first second of a spirometry test, expressed as a percentage of the predicted value for your age, height, and sex. Lower percentages mean more severe obstruction.

FEV-1/FVC (FEV-1 divided by Forced Vital Capacity) is the ratio of air expelled in the first second to the total air you can forcefully exhale. In healthy lungs, this ratio is typically 70-80% or higher. A low ratio indicates obstructive airway disease — which is exactly what asthma is.

For DC 6602, the VA uses both measurements independently. If your FEV-1 percentage falls in the 60% tier but your FEV-1/FVC ratio falls in the 30% tier, you get the higher rating. The VA is required to use the measurement that produces the most favorable result.

The Pre-Bronchodilator Gap: The Regulatory Loophole Most Veterans Miss

This is the single most underreported fact in asthma VA claims.

Under 38 CFR 4.96(d)(4), the VA requires that PFT ratings be based on post-bronchodilator results for certain diagnostic codes. The regulation explicitly lists DCs 6600, 6603, 6604, 6825-6833, and 6840-6845.

DC 6602 is not on that list.

That is not an oversight. BVA decision A25030824 (April 2025) confirmed that the Board will use whichever PFT result — pre-bronchodilator or post-bronchodilator — yields the most favorable rating for asthma claims under DC 6602.

Here is why this matters: bronchodilators are medications that open your airways. After you inhale a bronchodilator during a PFT, your results typically improve — sometimes dramatically. If you blow a pre-bronchodilator FEV-1 of 52% (60% tier) and a post-bronchodilator FEV-1 of 68% (30% tier), the VA should use the 52% number. But many C&P examiners and raters default to post-bronchodilator results out of habit, because that is the standard for COPD and other restrictive lung diseases.

How to Protect Yourself at the C&P Exam

Before your PFT, politely ask the examiner: "Will both pre-bronchodilator and post-bronchodilator results be recorded in the report?" If they say only post-bronchodilator, request that pre-bronchodilator values be included. You are entitled to this under the regulatory framework for DC 6602.

Medication-Based Criteria: Inhalational vs. Systemic Corticosteroids

This is the hidden threshold that separates 30% from 60% — and most veterans, VSOs, and even some VA raters do not understand the distinction.

Inhalational Corticosteroids = 30% Maximum

Medications like Flovent (fluticasone), Advair (fluticasone/salmeterol), Symbicort (budesonide/formoterol), Pulmicort (budesonide), and QVAR (beclomethasone) are inhalational anti-inflammatory medications. Under DC 6602, they qualify you for the 30% tier under the "inhalational anti-inflammatory medication" pathway. They do not qualify for 60%.

Systemic Corticosteroids = 60% Pathway

To reach 60% through the medication pathway, you need systemic corticosteroids — meaning oral or injectable steroids — at three or more courses per year. These include:

• Prednisone (oral) — the most common
• Methylprednisolone (oral or IV Solu-Medrol)
• Dexamethasone (oral or injectable)
• Triamcinolone (injectable)
• Prednisolone (oral)

If you go to the ER or urgent care three or more times per year for asthma exacerbations and receive a prednisone taper each time, that is your 60% pathway. The key evidence is your pharmacy records showing three or more fills of oral steroids within a 12-month period.

The 100% Medication Threshold

The 100% tier requires daily use of systemic high-dose corticosteroids or immunosuppressive medications. This is a very high bar. Veterans on daily prednisone maintenance, daily methotrexate, or biologics like omalizumab (Xolair) for severe refractory asthma may qualify. Documentation must show the medication is prescribed for asthma specifically, not for a comorbid condition like rheumatoid arthritis.

PACT Act Burn Pit Presumptive for Asthma

The PACT Act, signed into law on August 10, 2022, created presumptive service connection for asthma and numerous other respiratory conditions for veterans exposed to burn pits and other toxic substances during military service.

What "Presumptive" Means

Normally, to get service connection for a condition, you need three things: a current diagnosis, an in-service event or exposure, and a medical nexus linking the two. Presumptive service connection eliminates the nexus requirement. If you served in a covered location and have the diagnosed condition, the VA presumes it was caused by your service. No nexus letter required.

Who Qualifies

Veterans who served in any of the following qualify for the burn pit toxic exposure presumptive:

• Southwest Asia (Iraq, Kuwait, Saudi Arabia, etc.) on or after August 2, 1990
• Afghanistan, Syria, Jordan, Egypt, Lebanon, Yemen, Uzbekistan — on or after September 11, 2001
• Any location with a documented burn pit or toxic exposure as recognized by VA

Covered Respiratory Conditions

The PACT Act's presumptive list for toxic exposure includes:

• Asthma (diagnosed after discharge)
• Rhinitis
• Sinusitis (any form, within 10 years of service)
• Rhinosinusitis
• Laryngitis
• Constrictive bronchiolitis
• Lung cancers of any type
• And numerous other conditions

The OIG Error Problem

A December 2024 VA Office of Inspector General report found a 45% error rate in denied PACT Act claims. Errors included ordering unnecessary exams for presumptive conditions, failing to apply the correct presumptive framework, and processing mistakes that led to improper denials. If your asthma claim was denied under the PACT Act, there is a significant chance the denial itself contained a processing error — making it worth challenging through a Higher Level Review or Supplemental Claim.

The "Diagnosed After Service" Problem

Here is where it gets complicated. The PACT Act statute (38 U.S.C. 1120) specifies that asthma must be "diagnosed after service" for the presumptive to apply. The June 2024 VBA processing letter maintained this interpretation.

But in October 2024, the VA published a proposed rulemaking in the Federal Register that stated the opposite: requiring a post-service diagnosis "conflicts with the basic principle of presumptive service connection." The VA proposed to implement the asthma presumptive without the "diagnosed after service" qualifier.

As of March 2026, the proposed rule has not been finalized. This creates a two-track situation:

• If your asthma was diagnosed after discharge: You clearly qualify for the PACT Act presumptive. File under it.
• If your asthma was diagnosed before or during service: The presumptive does not currently apply under VBA guidance. However, you can pursue service connection through aggravation under 38 CFR 3.306 (proving burn pit exposure worsened your pre-existing condition), and if denied, you can cite the October 2024 Federal Register language as a regulatory argument on appeal.

Constrictive Bronchiolitis: When It Is Not Actually Asthma

Constrictive bronchiolitis (CB), also called bronchiolitis obliterans, is a serious condition that can mimic asthma symptoms but is fundamentally different. Where asthma involves reversible airway constriction, CB involves irreversible scarring of the small airways. The distinction matters enormously for VA claims.

How to Tell the Difference

• Asthma: Responds to bronchodilators. PFTs improve after inhaler use. Symptoms are episodic.
• Constrictive bronchiolitis: Does NOT respond to bronchodilators. PFTs show little or no improvement after inhaler use. Symptoms are progressive and constant.

If you were diagnosed with "exercise-induced asthma" or "reactive airway disease" after deployment and your symptoms do not improve with inhalers, ask your pulmonologist about constrictive bronchiolitis. A definitive diagnosis typically requires a surgical lung biopsy or high-resolution CT scan showing characteristic mosaic attenuation.

Why the Distinction Matters for Rating

CB is also on the PACT Act presumptive list. It is currently rated by analogy under DC 6600 (chronic bronchitis) or DC 6604 (chronic obstructive pulmonary disease). The VA published a Supplemental Notice of Proposed Rulemaking in 2024 proposing a dedicated diagnostic code for CB — but as of March 2026, this has not been finalized.

CB can also be established as secondary to service-connected asthma or chronic bronchitis, giving you an additional service-connection pathway even if the presumptive does not apply.

Secondary Conditions to Asthma

Service-connected asthma opens the door to secondary claims for conditions caused or aggravated by your asthma. These secondary conditions receive their own separate ratings and combine with your asthma rating under VA math.

Separately Ratable Secondary Conditions

These conditions fall outside the 38 CFR 4.96(a) anti-combination range and can be rated in addition to asthma:

• Allergic rhinitis (DC 6522) — Up to 30% with polyps, 10% without. Can be claimed as secondary to asthma through the shared inflammatory cascade. Also separately available as a PACT Act presumptive.
• Chronic sinusitis (DC 6510-6514) — Up to 50%. Also outside the anti-combination range. Available as PACT Act presumptive within 10 years of service.
• GERD / acid reflux (DC 7346) — Up to 60%. Asthma medications, especially inhaled corticosteroids, can cause or worsen GERD. The coughing and increased intra-abdominal pressure from asthma also contribute.
• Hypertension (DC 7101) — Up to 60%. Peer-reviewed research from 2024 links burn pit exposure to elevated cardiovascular risk, including a 5% increase in ischemic stroke risk per 100 days of exposure.
• Depression / anxiety (DC 9434/9413) — Up to 100%. Chronic respiratory disease with activity limitations and sleep disruption can cause or aggravate mental health conditions.
• Sleep disturbance — Nocturnal asthma is well-documented; sleep disruption secondary to asthma is a recognized pathway.

Conditions Blocked by 38 CFR 4.96(a)

These conditions cannot be rated separately from asthma:

• Sleep apnea (DC 6847) — falls within the anti-combination range
• COPD (DC 6604) — within the range
• Chronic bronchitis (DC 6600) — within the range
• Constrictive bronchiolitis (rated by analogy under DCs in-range)

The 38 CFR 4.96(a) Anti-Combination Rule

This is the structural constraint that catches the most veterans by surprise. Under 38 CFR 4.96(a), the VA is prohibited from assigning separate disability ratings for respiratory conditions rated under DCs 6600 through 6817 and DCs 6822 through 6847. Instead, the VA assigns a single rating based on the "predominant" disability.

For asthma veterans, this means:

• If you also have sleep apnea, you get ONE rating covering both conditions — not two separate ratings
• The single rating is assigned under whichever diagnostic code represents your predominant disability
• Under Urban v. Shulkin, all symptoms of both conditions must be considered when assigning that single rating

The Escape Hatch: Rhinitis and Sinusitis

Rhinitis (DC 6522) and sinusitis (DC 6510-6514) fall outside the 4.96(a) prohibition range. This is confirmed in the current regulatory text and has not changed despite proposed rulemaking. Under current law — file your cluster claims now:

• Asthma (DC 6602): up to 100%
• Rhinitis (DC 6522): up to 30%
• Sinusitis (DC 6510-6514): up to 50%

These three conditions can each receive their own separate rating and combine under VA math.

TDIU at 60%: The Backdoor to 100% Compensation

If your asthma is rated at 60% and it prevents you from maintaining substantially gainful employment, you qualify for Total Disability Based on Individual Unemployability (TDIU) under 38 CFR 4.16(a). TDIU pays at the full 100% rate.

The Math

TDIU at 60% is often more achievable than fighting for a schedular 100% — because the 100% PFT threshold (FEV-1 below 40% predicted) represents very severe airflow obstruction. Many veterans with debilitating asthma that prevents employment still have PFTs above 40%.

How to File for TDIU

1. File VA Form 21-8940 (Veteran's Application for Increased Compensation Based on Unemployability)
2. Document your employment history, income losses, and job terminations
3. Get statements from employers about work restrictions or termination due to your asthma
4. Get a medical opinion from your doctor stating your asthma prevents substantially gainful employment
5. The marginal employment income limit for 2026 is $16,749/year — if you earn less than this, you are considered unemployable

Extraschedular TDIU: The Sub-Threshold Safety Net

If your asthma is rated below 60% — say at 30% or even 10% — and you are genuinely unable to work because of it, you may still qualify for TDIU under 38 CFR 4.16(b). This is the extraschedular pathway.

Under 4.16(b), the VA rating board is required to refer your case to the Director of Compensation Service if the evidence shows you are unemployable but do not meet the percentage thresholds. This referral is mandatory, not discretionary. Grounds for referral include:

• Frequent hospitalization for asthma exacerbations
• Oxygen dependency
• Severe occupational limitations from dust, chemical, or environmental sensitivity
• Medical restrictions that eliminate most employment options

If the VA fails to refer your case when the evidence warrants it, that is a documentable appeal basis. Almost no veteran-facing content explains this pathway.

TDIU Effective Date: Back Pay You May Be Owed

Your TDIU effective date is not the date you filed the 21-8940 form. It is the later of: (a) the date the VA received your underlying service-connection or increased-rating claim, or (b) the date you first became unemployable due to your service-connected disabilities. If your original claim file contained evidence of unemployability — employer letters, medical restrictions, job loss — your TDIU effective date can be retroactive to that original claim date. This could mean years of back pay.

C&P Exam PFT Strategy

Your Compensation and Pension exam is where your rating is won or lost. For asthma claims, the PFT results and medication documentation are everything. Here is how to prepare.

Before the Exam

• Pull your complete pharmacy records showing all asthma medications for the past 12 months
• Count systemic corticosteroid prescriptions — if three or more, highlight them
• Get copies of any ER or urgent care visits for asthma exacerbations
• Document your worst days: frequency of attacks, nighttime awakenings, activity limitations
• Bring a list of all inhalers, nebulizer medications, and oral medications you currently take

During the PFT

• Ask that both pre-bronchodilator and post-bronchodilator values be recorded
• Ask that both FEV-1 and FEV-1/FVC be documented
• Do not use your rescue inhaler for at least 4-6 hours before the test (unless medically necessary)
• Give maximum effort on every attempt — the examiner records the best of three tries
• If you are having a bad asthma day, do not reschedule — your worst-day PFTs may produce the most accurate representation of your disability

After the Exam

Request a copy of the completed Disability Benefits Questionnaire (DBQ) from the VA. Check that:

• Pre-bronchodilator values are recorded (not just post-bronchodilator)
• Both FEV-1 and FEV-1/FVC are documented
• Your medication list accurately reflects systemic corticosteroid use
• The frequency of your exacerbations is correctly noted
• If anything is missing or incorrect, file a request for a new exam citing the specific deficiencies

Frequently Asked Questions